Evidence has shown that NF-κB mediates chemoresistance in AML, based on its ability to induce anti-apoptotic genes such as BCL-2 (B-cell lymphoma 2) and BCL-XL (B-cell lymphoma-extra-large) [22]. Here, BCL2L1 is linked to acute myeloid leukemia.